Anaconda announces first-in-human study of next-generation thrombectomy system

by CATALONIA.HEALTH

Anacon​da Biomed, a medical technology company developing a next-generation​ thrombectomy system for the treatment of ischemic stroke, has announced the completion of initial patient cases in a fi...

Read more

International collaboration between VHIR and UAB for Cerebral Infarction treatment

by Vall d’Hebron

Going forward, they will proceed with the development of RTU-009 as acombinationwith t-PA treatment for acute cerebral infarction as the top priority target

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream